Search for: "v. Teva Pharmaceuticals USA, Inc. et al" Results 1 - 20 of 116
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Federal Circuit Affirms Skinny Label Carve Outs
18 Jan 2024, 9:16 am by Fred Chung, Bradley Graveline and James Hurt
Lundbeck A/S, et al. v. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
FDA Recall Watch
17 Mar 2020, 1:32 pm by Noble McIntyre
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
Oklahoma Law Blog - http://www.oklahoma-law.com/blog/
Supreme Court End of Term Updates
19 Jun 2019, 6:18 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc. [read post]
Patently-O - http://patentlyo.com/patent
Federal Circuit Affirms Validity of Endo Pharmaceuticals Patent for Morphinan Pain Relief Compounds
16 May 2019, 8:15 am by Robert Schaffer & Joseph Robinson
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
The novelty of “on sale inventions” under a confidentiality agreement with regards to an “on sale” invention: the US Supreme Court rules
31 Jan 2019, 8:32 am
TEVA Pharmaceuticals USA INC., et al.,  had the opportunity to interpret the Leahy-Smith America Invents Act (AIA) with respect to how this impacts on the issue of the novelty of an invention. [read post]
IPKat - http://ipkitten.blogspot.com/
Jury Awards $6 Million to Former Employee in National Origin, Age Discrimination Case
7 Dec 2018, 10:38 am by Resnick Law Group, P.C.
Teva Pharmaceuticals USA, Inc., et al, No. 2:17-cv-00412, 2nd am. complaint (E.D. [read post]
The New Jersey Employment Law Firm Blog - http://www.thenjemploymentlawfirmblog.com/
Supreme Court Update – July 2018
23 Jul 2018, 12:05 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
Patently-O - http://patentlyo.com/patent
When are Confidential Sales Prior Art?
18 Jun 2018, 9:15 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229 (Supreme Court 2018), the petitioner has asked the Supreme Court to offer its statement on whether Congress altered the “on sale bar” to now apply only to non-confidential sales or offers. [read post]
Patently-O - http://patentlyo.com/patent
Federal Court Dismisses CFAA Claims Against Former Executive, Allows CFAA and DTSA Claims Against Competitor in Pharmaceuticals Trade Secret Dispute
18 Apr 2018, 1:02 pm by Kevin Mahoney
In Teva Pharmaceutical USA, Inc. v. [read post]
Trading Secrets - http://www.tradesecretslaw.com/
$235 Million Verdict of Willful Induced Infringement Overruled for Failure to Prove Causation
30 Mar 2018, 7:13 am by Docket Navigator
Teva Pharmaceuticals USA, Inc., 1-14-cv-00878 (DED March 28, 2018, Order) (Stark, USDJ) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Allegan’s Restasis Patents Invalidated by a Federal District Court Even After Transfer to Native American Tribe and Sovereign Immunity Claim.
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
IP Law Blog - http://www.theiplawblog.com/
Allegan’s Restasis Patents Invalidated by a Federal District Court Even After Transfer to Native American Tribe and Sovereign Immunity Claim.
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
IP Law Blog - http://www.theiplawblog.com/
Commercial Success of Restasis Does Not Support Finding of Non-Obviousness Because Blocking Patents Suppressed Competition
19 Oct 2017, 7:36 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED October 16, 2017, Order) (Bryson, CJ) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Defendant’s Stipulation to Infringement "Under the Present Claim Construction" Does Not Justify Change in Order of Proof at Trial​
29 Aug 2017, 7:35 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED August 25, 2017, Order) (Bryson, CJ) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Attorney Fees for Resisting Motion to Compel Not Recoverable
12 Apr 2017, 7:13 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED April 10, 2017, Order) (Bryson, CJ) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Judge Andrews Grants in Part Teva’s Motion to Dismiss ANDA Complaint
10 Feb 2017, 10:52 am by Gregory B. Williams
Andrews in Endo Pharmaceuticals Inc. et al. v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Supreme Court Update: Are Secondary Indicia of Invention Relevant to Eligibility?
8 Feb 2017, 3:09 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
Patently-O - http://patentlyo.com/patent
Supreme Court 2017 – Patent Preview
16 Jan 2017, 5:44 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
Patently-O - http://patentlyo.com/patent
Supreme Court Patent Cases: Post Sale Exhaustion
14 Nov 2016, 9:16 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
Patently-O - http://patentlyo.com/patent
Supreme Court Update: Extending the ITC’s Reach Beyond US Borders
13 Oct 2016, 6:50 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
Patently-O - http://patentlyo.com/patent